WHO and Gilead Sciences extend collaboration against visceral leishmaniasis

Treatment against visceral leishmaniasis, South Sudan
© J. A. Ruiz Postigo / WHO

27 September 2016 ¦ Geneva –– The World Health Organization (WHO) and Gilead Sciences have signed a new agreement that allows the pharmaceutical company to donate medicines for the treatment of visceral leishmaniasis.
Under the new 5-year collaboration and until 2021, Gilead Sciences have also agreed to provide financial assistance for the expansion of leishmaniasis surveillance and control.
Visceral leishmaniasis is endemic in more than 80 countries worldwide.

New leishmaniasis country profiles based on routine surveillance data

© Getty images

14 July 2016 | Geneva −−The World Health Organization (WHO) is leading an effort to leverage routine leishmaniasis surveillance data from 25 high-burden countries from WHO regions to create new profiles.

The data include breakdown of new, relapse and imported cases; populations at risk; control and surveillance (including latest national guidelines, number of leishmaniasis health facilities), diagnosis (such as number of people screened, proportion of positive rapid diagnostic tests) and treatment including initial cure and case-fatality rates.

WHO to implement online epidemiological surveillance for leishmaniasis

©HISP Uganda Team

21 June 2016 | Geneva −− The World Health Organization (WHO) is supporting the use of a new data system to ensure the accurate, sustained flow of information for leishmaniasis. An improved dissemination and understanding of the problem posed by all forms of the disease can greatly help control programmes and allow countries to improve their surveillance systems.

Data from 25 countries with high disease prevalence show an estimated 399 million people are at risk of cutaneous leishmaniasis in 11 countries, while 556 million are exposed to visceral leishmaniasis 12 countries.


Explore some of the issues surrounding visceral leishmaniasis in Africa and in India, and cutaneous leishmaniasis in South America. Watch the trailer of "A trilogy of injustice"

Photo gallery

Learn about the disease


Dr José Antonio Ruiz Postigo
Leishmaniasis Control Programme
+41 22 791 3870
+41 79 516 3882 (mobile)

Media contact:
Ashok Moloo
+41 22 791 1637
+41 79 540 50 86 (mobile)